A notable example is triple-negative breast cancer (negative for ERBB2 (Her2/neu), estrogen receptor, and progesterone receptor protein expression), which is typically an aggressive tumor that does not respond to targeted chemotherapy agents [30]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.